Clinical Trial Links Oncolytic Immunoactivation to Survival in Glioblastoma

By
Noshin Noorjahan
-
0
342
Scientists reported the results of a first-in-human phase I trial in 41 patients with recurrent glioblastoma who were injected with CAN-3110—an oncolytic herpes virus.
[Nature]
Full Article